The UCSF School of Pharmacy was a key collaborator in the early January 2009 launch of a course in China that ultimately hopes to contribute to the improved quality and broader acceptance of Chinese pharmaceuticals and pharmaceutical exports.
The path from scientific insight to a new drug used to treat patients is a long, expensive, inefficient, hazard-strewn obstacle course requiring many steps before the drug arrives at the pharmacy. Unfortunately, the specialists working at each of these steps do not necessarily have a clear vision of what goes on outside their own areas of expertise. As a result, they can be unaware of how the decisions they make impact other points in the cycle of drug or medical product development.
Historical underfunding of the UCSF School of Pharmacy, which has been exacerbated by successive California state budget cuts, threatens the School's ability to retain accreditation status of its doctor of pharmacy program, explains the School's dean, Mary Anne Koda-Kimble, PharmD.
The UCSF School of Pharmacy continues to rank #1 among Doctor of Pharmacy (PharmD) degree programs in the United States according to results of a survey conducted in 2007 and published online on March 26, 2008 by U.S. News & World Report.
UCSF School of Pharmacy faculty members and students were recognized with three honors at the 2008 annual meeting of the American Pharmacists Association (APhA) held March 14-17, 2008 in San Diego, California.